All data are based on the daily closing price as of July 18, 2024
p

Peptron

087010.KQ
46.29 USD
-5.89
-11.29%

Overview

Last close
46.29 usd
Market cap
709.48M usd
52 week high
53.20 usd
52 week low
5.35 usd
Target price
25.32 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
151.4244
Price/Book Value
13.9951
Enterprise Value
368.70M usd
EV/Revenue
152.5337
EV/EBITDA
-40.2951

Key financials

Revenue TTM
4.20M usd
Gross Profit TTM
3.23M usd
EBITDA TTM
-7.77M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
37.07M usd
Net debt
N/A usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
  • Symbol
    087010.KQ
  • Exchange
    KQ
  • Isin
    KR7087010005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology & Medical Research
  • CEO
    Mr. Ho-Il Choi
  • Headquarter
    Daejeon
  • Web site
    http://www.peptron.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top